長崎 幸夫(ナガサキ ユキオ)
- 会議発表等
- Functional role of novel short-chain fatty acidnano-medicine as a radio-sensitizer to improve cancer therapy
Shashni Babita; Nagasaki Yukio
第44回日本バイオマテリアル学会大会/2022-11 - Novel nano-delivery system for microbial metabolite short-chain fatty acid ameliorates non-alcoholic steatohepatitis and fibrosis
Shashni Babita; Tajika Yuya; Nishikawa Yuji; Nagasaki Yukio
第44回日本バイオマテリアル学会大会/2022-11 - 抗がん治療に向けたシステインナノ粒子の設計と薬理効果発現
甲田優太; 長崎 幸夫
第44回日本バイオマテリアル学会大会/2022-11 - 抗酸化ナノメディシンによる運動誘発性胃腸症候群と運動能力への効果の検証
鳥海拓都; 大森 肇; 長崎 幸夫
第44回日本バイオマテリアル学会大会/2022-11 - 低酸素環境応答性プロドラッグの開発と化学放射線療法への展開
池田 豊; 西川祐司; 長崎 幸夫
がんとハイポキシア研究会/2022-11 - Butyric acid-based prodrug sensitizes cancer to the radiation therapy
Shashni Babita; Nagasaki Yukio
5th G'L'owing Polymer Symposium in KANTO/2022-12 - Design of Hepatoprotective Ornithine-Based Self-Assembling Prodrugs for Attenuation of Acetamin
Ding Yuanyuan; Koda Yuta; Shashni Babita; Takeda Naoki; Z...
5th G'L'owing Polymer Symposium in KANTO/2022-12 - Cystine-Based Nanoparticles Suppressing Tumor Growth on Xenograft Mice Model of Colon Cancer
KODA Yuta; Nagasaki Yukio
第32回日本MRS年次大会/2022-12 - Antioxidant nanomedicine retained in the gastrointestinal tract improves exercise performance
Toriumi T.; Ohmori H.; Nagasaki Yukio
第32回日本MRS年次大会/2022-12 - システインの抗酸化能を飛躍的に向上させるナノ粒子化薬の開発１：固形がんに対する抗腫瘍効果
甲田優太; 長崎 幸夫
第35回日本酸化ストレス学会関東支部会/2022-12 - システインの抗酸化能を飛躍的に向上させるナノ粒子化薬の開発２：非アルコール性脂肪肝炎(NASH)に対する治療効果
甲田優太; 長崎 幸夫
第35回日本酸化ストレス学会関東支部会/2022-12 - 腸内ROS消去が走運動パフォーマンスを向上させる
鳥海拓都; 大森 肇; Nagasaki Yukio
第35回日本酸化ストレス学会関東支部会/2022-12 - Novel antioxidant nano-carrier attenuates pathogenesis of oxidative stress-related diseases
Shashni Babita; Tamaoki Junya; Kobayashi Makoto; Nagasaki...
10th Joint Meeting of Society for Free Radical Research Australasia and Japan/2022-12 - Elimination of gastrointestinal reactive oxygen species enhances exercise performance
Toriumi Takuto; Ohmori Hajime; Nagasaki Yukio
10th Joint Meeting of Society for Free Radical Research Australasia and Japan/2022-12 - Neuroprotective effect on traumatic brain injury using redox nanoparticles in mice
Marushima A.; Takahashi T.; Nagasaki Yukio; Hirayama A; M...
15th International Neurotrauma Symposium/2022-07 - Enzyme metabolizable PEG-b-poly(vinyl butyrate) nanomedicine sensitizes cancer to the radiotherapy
Shashni Babita; Nagasaki Yukio
84th Prague Meeting on Macromolecules (PMM), Frontiers of Polymer Colloids -From Synthesis to Macro-scale and Nano-scale Applicatoins/2022-07 - Design of nanomedicine based on polycysteine suppressing C26-tumor growth on a xenograft mouse model
Koda Yuta; Nagasaki Yukio
10th Joint Meeting of Society for Free Radical Research Australasia and Japan/2022-12 - Oral administration of silymarin-loaded siica-installed redox nanoparticle for an effective therapy in inflammatory bowel disease
Nguyen Thi Thu-Ha; Trinh Nhu-Thuy; Nagasaki Yukio; Binh L...
9th International Conference in Vietnam on the Development of Biomedical Engineering (BME9)/2022-12 - 腸内活性酸素を除去するナノ粒子 －うつ病治療の新しいアプローチ－
池田 豊; 齋江 直輝; 長崎 幸夫
第38回日本DDS学会学術集会若手シンポジウム/2022-06 - 分子組織化を基盤とする新しい創薬
長崎 幸夫
学術領域研究(B) 「高分子進化工学」第一回領域会議/2022-07 - Pharmacologically active polymer micelles for novel therapeutics
Nagasaki Yukio
84th Prague Meeting on Macromolecules (PMM), Frontiers of Polymer Colloids -From Synthesis to Macro-scale and Nano-scale Applicatoins/2022-07 - Molecular design of Self-assembling drugs
Nagasaki Yukio
Gelsympo2022/2022-09 - Antioxidant nanoparticles that scavenge the intestinal ROS lead to health
長崎 幸夫
12th International Forum on Post-Genome Symposium (IFPT'12; Online)/2022-10 - Direct evidence for the involvement of intestinal reactive oxygen species in the progress of depression via the gut-brain axis
Nagasaki Yukio
the 10th Bienimal Meeting of the Society for Free Radical Research, Asia (SFRR-Asia 2022, Seoul, Korea)/2022-11 - Antioxidant Nanoparticle for Oxidative Stress Diseases
Nagasaki Yukio
10th Joint Meeting of Society for Free Radical Research Australasia and Japan/2022-12 - さらに表示...
- Functional role of novel short-chain fatty acidnano-medicine as a radio-sensitizer to improve cancer therapy